LiDCO Group plc (LON:LID)‘s stock had its “corporate” rating restated by stock analysts at FinnCap in a research report issued on Tuesday, May 30th. They currently have a GBX 14 ($0.18) price objective on the stock. FinnCap’s target price would indicate a potential upside of 77.78% from the company’s previous close.

LiDCO Group plc (LON:LID) opened at 7.875 on Tuesday. The firm’s market capitalization is GBX 19.23 million. LiDCO Group plc has a 52-week low of GBX 5.25 and a 52-week high of GBX 9.00. The firm has a 50-day moving average price of GBX 7.82 and a 200 day moving average price of GBX 6.84.

TRADEMARK VIOLATION WARNING: This report was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The legal version of this report can be viewed at

In other news, insider Peter Grant purchased 500,000 shares of the company’s stock in a transaction on Friday, March 31st. The stock was bought at an average cost of GBX 3 ($0.04) per share, for a total transaction of £15,000 ($18,975.33).

About LiDCO Group plc

LiDCO Group Plc is a United Kingdom-based supplier of non-invasive and minimally invasive hemodynamic monitoring equipment to hospitals. The Company is engaged in the development, manufacture and sale of cardiac monitoring equipment. It operates in the segment of supply of monitors, consumables and support services associated with the use of its cardiac monitoring equipment.

Receive News & Stock Ratings for LiDCO Group plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiDCO Group plc and related stocks with our FREE daily email newsletter.